A History of the Pharmacological Treatment of Bipolar Disorder



Downloads per month over past year

López-Muñoz, Francisco and Shen, Winston and D’Ocon, Pilar and Romero Martínez, Manuel Alejandro and Álamo, Cecilio (2018) A History of the Pharmacological Treatment of Bipolar Disorder. International Journal of Molecular Sciences, 19 (7). p. 2143. ISSN 1422-0067

[thumbnail of ijms-19-02143.pdf] PDF
Creative Commons Attribution.


Official URL: https://doi.org/10.3390/ijms19072143


In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade’s experiments with lithium and the beginning of the so-called “Psychopharmacological Revolution” in the 1950s. We also describe the clinical studies and development processes, enabling the therapeutic introduction of pharmacological agents currently available for the treatment of bipolar disorder in its different phases and manifestations. Those drugs include lithium salts, valproic acid, carbamazepine, new antiepileptic drugs, basically lamotrigine and atypical antipsychotic agents (olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, asenapine, cariprazine and lurasidone). Finally, the socio-sanitary implications derived from the clinical introduction of these drugs are also discussed.

Item Type:Article
Uncontrolled Keywords:bipolar disorder; pharmacological treatment; mood stabilizer drugs; lithium; antiepileptic drugs; antipsychotic drugs
Subjects:Medical sciences > Medicine > Psychiatry
Medical sciences > Veterinary > Veterinary pharmacology
Medical sciences > Pharmacy > Pharmacology
ID Code:64705
Deposited On:19 Apr 2021 14:51
Last Modified:20 Apr 2021 08:20

Origin of downloads

Repository Staff Only: item control page